血浆脂联素检测在冠心病患者中的临床意义  

The Clinical Significance of the Plasma Adiponectin Test in Coronary Heart Disease

作　　者：李道远 任春琦 玛依努尔.斯买拉洪 

机构地区：[1]山东省潍坊市第二人民医院,山东潍坊261000 [2]北京市平谷区医院 [3]乌鲁木齐市自治区中医医院

出　　处：《中国医学创新》2013年第23期134-136,共3页Medical Innovation of China

摘　　要：目的:探讨血浆脂联素(APN)水平在冠心病患者中的临床意义,以及其在冠心病发生、发展中的作用。方法:选取确诊为冠心病患者共80例,其中稳定型心绞痛组45例,不稳定型心绞痛组35例,并且选取30例正常健康人作为对照组,检测血浆APN水平,同时检测LDL-C、HDL-C,并对检测结果进行分析。结果:冠心病患者APN水平明显低于对照组,两组比较差异有统计学意义(P<0.05);不稳定型心绞痛组APN水平低于稳定型心绞痛组(P<0.05)。结论:脂连素可能为冠心病的一个保护因子,其与冠心病的发生发展呈负相关,为诊断冠心病提供了临床依据。Objective： To investigate clinical significance of the plasma adiponectin （ APN ） level in patients with coronary heart disease, anti rote in the development of coronary heart disease.Method： 80 cases of patients with coronary heart disease, stable angina pectoris group of 45 cases, unstable angina group of 35 cases, 30 cases of normal healthy people as a control group, p!asma APN level, LDL -C, HDL-C were detected, and the results were analyzed.Result： In patients with coronary heart disease APN levels were significantly lower than those in the control group, the difference was statistically significant （ P〈0.05 ） ; unstable angina group APN level was lower than the stable angina group （ P〈0.05 ） . Conclusion： Adiponectin may be a protective factor for coronary heart disease, and is negatively correlated with the development of coronary heart disease, also provide the clinical basis for the diagnosis of coronary heart disease.

关 键 词：脂连素 冠心病 

分 类 号：R541.4[医药卫生—心血管疾病]